BioTime signs deal to access new device for sub-retinal delivery of OpRegen cells
BioTime has entered into a research and option agreement with Orbit Biomedical to access new device for the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Jan 19
BioTime has entered into a research and option agreement with Orbit Biomedical to access new device for the…
04 Jan 19
FUJIFILM Cellular Dynamics (FCDI), a subsidiary of FUJIFILM, is investing $21m to open a new cGMP-compliant production facility…
21 Dec 18
Beaver-Visitec International (BVI) has agreed to acquire Belgium-based ophthalmic firm PhysIOL Group for an undisclosed sum.
18 Dec 18
Notal Vision has announced the achievement of a significant milestone in its plan to develop and commercialize a…
13 Dec 18
Glaukos, an ophthalmic medical technology, has published positive results from new study on iStent inject Trabecular Micro-Bypass System.
04 Dec 18
Implandata Ophthalmic Products has implanted the first patient with its EYEMATE-SC, a new pressure sensor for continual monitoring…
29 Oct 18
Clinical-stage biopharma company GenSight Biologics said that the first patient has been treated in a first-in-man trial assessing…
26 Oct 18
Medical device firm NovioSense has reported positive data from its NLNSGS2017-02 phase 2 study of tear glucose sensor…
24 Oct 18
Alcon, an eye care division of Novartis, has unveiled plans for the development of SMART Suite digital platform…
24 Oct 18
Carl Zeiss Meditec has agreed to acquire IanTECH, a privately held company focused on technology solutions for micro-interventional…